(Reuters) -Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed ...

A pair of drugmakers priced their initial public offerings on Thursday, delivering the best month for US health care ...

French AI startup Mistral unveils a breakthrough 24B parameter language model that matches the performance of models three ...

Gaming mergers and acquisitions (M&A) and financings in 2024 grew 39% to $27.3 billion in disclosed deal value across over 967 transactions, according to a report by Drake Star Partners. That’s a ...

Private equity-backed oil and natural gas producer Infinity Natural Resources on Thursday raised $265 million in its initial ...

Bally's announced a $250 million public offering last month for shares of their massive Chicago casino project, but only to women or people of color. That's according to terms of the company's ...

Beta Bionics has begun life as a public company with a $204m initial public offering (IPO), significantly higher than its anticipated target. The US-based company sold 12 million shares of its common ...

Castore also provide kit for Premier League teams Newcastle and Aston Villa, with Everton joining the list next season. Overseas, the likes of Feyenoord and Bayer Leverkusen are among their customer ...

Discover new preferred stock and exchange-traded debt offerings in January with yields up to 9.125%. Click here to read what ...

BW LPG’s track record is solid, with a 16% return on equity and $12 per share paid out in dividends since the IPO in 2013. (Copyright) ...

Included Health filed its S-1 for an IPO that never happened. Its CEO said the company went heads-down to reach profitability and sales growth.

As most followers of the PIMCO Dynamic Income Strategy fund (PDX) know, the rapid-growth trajectory of the fund has been ...